132 related articles for article (PubMed ID: 11897760)
1. Smoking impairs bradykinin-stimulated t-PA release.
Pretorius M; Rosenbaum DA; Lefebvre J; Vaughan DE; Brown NJ
Hypertension; 2002 Mar; 39(3):767-71. PubMed ID: 11897760
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin-converting enzyme inhibition increases human vascular tissue-type plasminogen activator release through endogenous bradykinin.
Pretorius M; Rosenbaum D; Vaughan DE; Brown NJ
Circulation; 2003 Feb; 107(4):579-85. PubMed ID: 12566370
[TBL] [Abstract][Full Text] [Related]
3. Regulation of local tissue-type plasminogen activator release by endothelium-dependent and endothelium-independent agonists in human vasculature.
Stein CM; Brown N; Vaughan DE; Lang CC; Wood AJ
J Am Coll Cardiol; 1998 Jul; 32(1):117-22. PubMed ID: 9669258
[TBL] [Abstract][Full Text] [Related]
4. Bradykinin stimulates tissue plasminogen activator release in human vasculature.
Brown NJ; Gainer JV; Stein CM; Vaughan DE
Hypertension; 1999 Jun; 33(6):1431-5. PubMed ID: 10373228
[TBL] [Abstract][Full Text] [Related]
5. Potentiation of bradykinin-induced tissue plasminogen activator release by angiotensin-converting enzyme inhibition.
Labinjoh C; Newby DE; Pellegrini MP; Johnston NR; Boon NA; Webb DJ
J Am Coll Cardiol; 2001 Nov; 38(5):1402-8. PubMed ID: 11691515
[TBL] [Abstract][Full Text] [Related]
6. Marked impairment of protease-activated receptor type 1-mediated vasodilation and fibrinolysis in cigarette smokers: smoking, thrombin, and vascular responses in vivo.
Lang NN; Gudmundsdóttir IJ; Boon NA; Ludlam CA; Fox KA; Newby DE
J Am Coll Cardiol; 2008 Jul; 52(1):33-9. PubMed ID: 18582632
[TBL] [Abstract][Full Text] [Related]
7. Bradykinin type 2 receptor BE1 genotype influences bradykinin-dependent vasodilation during angiotensin-converting enzyme inhibition.
Van Guilder GP; Pretorius M; Luther JM; Byrd JB; Hill K; Gainer JV; Brown NJ
Hypertension; 2008 Feb; 51(2):454-9. PubMed ID: 18180402
[TBL] [Abstract][Full Text] [Related]
8. Bradykinin stimulates tissue plasminogen activator release from human forearm vasculature through B(2) receptor-dependent, NO synthase-independent, and cyclooxygenase-independent pathway.
Brown NJ; Gainer JV; Murphey LJ; Vaughan DE
Circulation; 2000 Oct; 102(18):2190-6. PubMed ID: 11056091
[TBL] [Abstract][Full Text] [Related]
9. Preserved tissue-type plasminogen activator release and endothelium-dependent vasodilation in postmenopausal women with NIDDM.
Manhem K; Dotevall A; Wilhelmsen L; Jern S
J Diabetes Complications; 2000; 14(3):127-34. PubMed ID: 10989320
[TBL] [Abstract][Full Text] [Related]
10. Fibrinolytic actions of intra-arterial angiotensin II and bradykinin in vivo in man.
Labinjoh C; Newby DE; Dawson P; Johnston NR; Ludlam CA; Boon NA; Webb DJ
Cardiovasc Res; 2000 Sep; 47(4):707-14. PubMed ID: 10974219
[TBL] [Abstract][Full Text] [Related]
11. Endogenous nitric oxide contributes to bradykinin-stimulated glucose uptake but attenuates vascular tissue-type plasminogen activator release.
Pretorius M; Brown NJ
J Pharmacol Exp Ther; 2010 Jan; 332(1):291-7. PubMed ID: 19841473
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin-converting enzyme inhibition increases basal vascular tissue plasminogen activator release in women but not in men.
Pretorius M; Luther JM; Murphey LJ; Vaughan DE; Brown NJ
Arterioscler Thromb Vasc Biol; 2005 Nov; 25(11):2435-40. PubMed ID: 16166566
[TBL] [Abstract][Full Text] [Related]
13. Release of tissue-type plasminogen activator in response to muscarinic receptor stimulation in human forearm.
Jern S; Selin L; Bergbrant A; Jern C
Thromb Haemost; 1994 Oct; 72(4):588-94. PubMed ID: 7878638
[TBL] [Abstract][Full Text] [Related]
14. Endothelium-derived hyperpolarizing factor mediates bradykinin-stimulated tissue plasminogen activator release in humans.
Rahman AM; Murrow JR; Ozkor MA; Kavtaradze N; Lin J; De Staercke C; Hooper WC; Manatunga A; Hayek S; Quyyumi AA
J Vasc Res; 2014; 51(3):200-8. PubMed ID: 24925526
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin-(1-7) does not affect vasodilator or TPA responses to bradykinin in human forearm.
Wilsdorf T; Gainer JV; Murphey LJ; Vaughan DE; Brown NJ
Hypertension; 2001 Apr; 37(4):1136-40. PubMed ID: 11304515
[TBL] [Abstract][Full Text] [Related]
16. 17Beta-estradiol increases basal but not bradykinin-stimulated release of active t-PA in young postmenopausal women.
Pretorius M; van Guilder GP; Guzman RJ; Luther JM; Brown NJ
Hypertension; 2008 Apr; 51(4):1190-6. PubMed ID: 18259028
[TBL] [Abstract][Full Text] [Related]
17. Influence of oral contraceptive use on endothelial t-PA release in healthy premenopausal women.
Hoetzer GL; Stauffer BL; Greiner JJ; Casas Y; Smith DT; DeSouza CA
Am J Physiol Endocrinol Metab; 2003 Jan; 284(1):E90-5. PubMed ID: 12388132
[TBL] [Abstract][Full Text] [Related]
18. Vasomotor and fibrinolytic responses to kinin receptor agonists in the atherosclerotic human lower limb.
Cruden NL; Lang NN; MacGillivray TJ; Uren NG; Fox KA; Newby DE
Heart Vessels; 2012 Mar; 27(2):179-85. PubMed ID: 21394642
[TBL] [Abstract][Full Text] [Related]
19. High capacity for tissue-type plasminogen activator release from vascular endothelium in vivo.
Wall U; Jern C; Jern S
J Hypertens; 1997 Dec; 15(12 Pt 2):1641-7. PubMed ID: 9488216
[TBL] [Abstract][Full Text] [Related]
20. Nitric oxide modulates tissue plasminogen activator release in normotensive subjects and hypertensive patients.
Giannarelli C; De Negri F; Virdis A; Ghiadoni L; Cipriano A; Magagna A; Taddei S; Salvetti A
Hypertension; 2007 Apr; 49(4):878-84. PubMed ID: 17339540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
